Govt scraps repeat tests on animals for drugs in use abroad

Image
Press Trust of India New Delhi
Last Updated : Mar 18 2016 | 7:14 PM IST
Repeat tests on animals for drugs which have already been approved by other countries will not be necessary from now on in India, the Centre has said with the move being hailed by animal rights bodies.
The Union Health Ministry has amended Schedule Y of the Drugs and Cosmetics Rules, 1945, which states that animals will be spared the cruel tests for new drug registrations where complete data from similar toxicity experiments already exists for drugs approved abroad.
"Where the data on animal toxicity... Has been submitted and the same has been considered by the regulatory authority of the country which had earlier approved the drug, the animal toxicity studies shall not be required to be conducted in India except in cases where there are specific concerns recorded in writing," said a notification signed by the ministry's joint secretary, KL Sharma.
The amendments follow repeated appeals by People for the Ethical Treatment of Animals (PETA) India and Union minister Maneka Gandhi, a well-known animal rights activist.
Explaining the amendment, a senior PETA official said if a particular drug, which is being introduced in India, has been approved in a particular country after tests on animals, then conducting such tests again for the same drug here will not be required.
The notification says that no permission will be required to conduct clinical trial intended for academic purposes in respect of approved drug formulation for "any new indication or new route of administration or new dose or new dosage form where the trial is approved by the Ethics Committee and subject to the provisions of sub-rule 5, the data generated is not intended for submission to licensing authority".
According to PETA India Research Associate Dipti Kapoor, "by banning redundant and painful tests on animals, the Indian government will spare the lives of potentially hundreds of thousands of animals in repeat experiments each year".
(REOPENS DEL66)
PETA said that last year, upon reviewing the requests from PETA and Maneka Gandhi, the Indian Investigational New Drugs Division recommended to the Drug Technical Advisory Board (DTAB) that animals be spared cruel tests for new drug registrations when complete data from earlier toxicity experiments already exist for drugs approved abroad.
PETA supporter and X-Files star Gillian Anderson, who was in India for a movie, had also written to the Union Health Minister requesting a ban on repeat experiments on animals in toxicity tests by amending the Drugs and Cosmetics Rules, 1945, PETA said.
"We welcome this move by the health ministry. The new amendment will not only save thousands of animals every year from being subjected to redundant animal testing, it also marks the beginning of a potential new era of sophisticated animal testing alternatives in India.
"We look forward to continuing our association with the ministry to ensure that use of validated alternatives is encouraged as the Drug Technical Advisory Board has recommended," said Gauri Maulekhi, Humane Society International, India consultant.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 18 2016 | 7:14 PM IST

Next Story